-
Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue
Monday, August 29, 2011 - 1:33am | 123Below are the top large-cap medical instruments & supplies stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Baxter International Inc (NYSE: BAX) is $13.54 billion. BAX's PEG ratio is 1.29. The trailing-twelve-month revenue at Thermo Fisher Scientific...
-
Top 4 Large-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue
Monday, August 29, 2011 - 1:31am | 123Below are the top large-cap medical instruments & supplies stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Baxter International Inc (NYSE: BAX) is $13.54 billion. BAX's PEG ratio is 1.29. The trailing-twelve-month revenue at Thermo Fisher Scientific...
-
Are Stock Buybacks Always Beneficial?
Friday, August 26, 2011 - 1:44pm | 423Stock repurchase programs are a common way for companies to invest in themselves and boost value for shareholders. On the morning of August 26, Varian Medical Systems (NYSE: VAR) announced that it would extend its revolving credit facility with Bank of America (NYSE: BAC) in order to repurchase $...
-
Conceptus Enters Into New Revolving Line of Credit Agreement With Wells Fargo Bank
Friday, August 26, 2011 - 9:04am | 58Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure procedure, the most effective non-surgical permanent birth control method available, today announced that it has entered into a new revolving line of credit arrangement with Wells Fargo Bank, N.A., providing the Company a working capital...
-
Varian Medical Systems Announces $250M Accelerated Stock Repurchase; Increases Its Revolving Credit Facility
Friday, August 26, 2011 - 8:32am | 170Varian Medical Systems (NYSE: VAR) today announced that it has entered into an agreement with Bank of America, N.A. to repurchase $250 million of its common stock under an accelerated share repurchase program. Concurrently, the company amended its revolving credit facility with Bank of America, N....
-
UPDATE: Jefferies Lowers PT on Cyberonics to $33
Friday, August 26, 2011 - 8:31am | 98Jefferies is out with its report today on Cyberonics (NASDAQ: CYBX), lowering its PT to $33 from $37. In its report, Jefferies writes, "Cyberonics posted an overall good F1Q, as the US growth softness that lingered from last quarter was offset by a rebound internationally, suggesting the European...
-
Stifel Nicolaus Initiates ECTE, SONO At Buy
Friday, August 26, 2011 - 8:05am | 36Stifel Nicolaus has initiated coverage on the following companies: Echo Therapeutics (NASDAQ: ECTE) Buy, $5 PT SonoSite (NASDAQ: SONO) Buy, $44 PT
-
Bank of America Merrill Lynch Has Buy On IDEXX Laboratories
Friday, August 26, 2011 - 7:55am | 147Bank of America Merrill Lynch is out with a research report on IDEXX Laboratories (NASDAQ: IDXX) and it has a Buy rating and a $89 price target on shares. In a note to clients, Bank of America Merrill Lynch writes, "PDCO also announced the acquisition of American Veterinary Supply Corp. (AVSC), a...
-
Jefferies Lowers PT On Cyberonics To $33
Friday, August 26, 2011 - 7:10am | 26Jefferies & Company has lowered the price target on Cyberonics (NASDAQ: CYBX) from $37 to $33 and maintains its Buy rating.
-
UPDATE: Piper Jaffray Lowers PT on Cyberonics from $35 to $34
Friday, August 26, 2011 - 7:06am | 102Piper Jaffray has published a research report on Cyberonics (NASDAQ: CYBX). In the report, Piper Jaffray wrote, "CYBX reported solid FQ1-12 results, with revenues (up 18%) and earnings (up 11%) higher than PJC and the Street. OUS issues identified earlier this year appear to be resolving with OUS...
-
Piper Jaffray Lowers PT On Cyberonics To $34
Friday, August 26, 2011 - 5:55am | 26Piper Jaffray has lowered the price target on Cyberonics (NASDAQ: CYBX) from $35 to $34 and maintains its Overweight rating.
-
Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2012 and Comments on Fiscal 2011 Guidance
Thursday, August 25, 2011 - 11:00am | 232Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company's fiscal 2012 sales and earnings estimates. Based on the Company's business planning and budgeting activities for the fiscal year ending September 30, 2012, management expects net...
-
Market Update
Thursday, August 25, 2011 - 9:32am | 148Shares of Willis Group Holdings plc (NYSE: WSH) gained about 1.3% after Willis Europe BV, a division of Willis Group Holdings acquired 100% of the shares of Polish insurance broker, Brokerskie Centrum Ubezpieczeniowe Sp. Zoo. Shares of Prospect Capital Corporation (NASDAQ: PSEC) rose about 2%...
-
Bank of America Comments on St Jude Medical
Thursday, August 25, 2011 - 7:33am | 73Bank of America has published a research report on St Jude Medical (NYSE: STJ). In the report, Bank of America wrote, "With MDT's report yesterday all public CRM companies have now reported for Q2. CRM makes up 30% of MDT, 55% of STJ and 27.5% of BSX revenues." Bank of America rated St. Jude...
-
Baxter to Acquire Privately Held Baxa Corporation
Thursday, August 25, 2011 - 7:30am | 83Baxter International Inc. (NYSE: BAX) announced today that it has entered into a definitive agreement to acquire Baxa Corporation, a privately held company based in Englewood, Colo., with additional operations in Florida and the United Kingdom. Baxa develops pharmacy technology that enhances the...